Found 84 Enz. Inhib. hit(s) with all data for entry = 9137 TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.234nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.391nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: <0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: <0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: <0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: <0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: <0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.515nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.560nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.641nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.671nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.685nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.740nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.860nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.861nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.989nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 0.994nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.01nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.04nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.25nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.49nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.87nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 1.99nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.02nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.23nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.24nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.53nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.60nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.70nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 2.81nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.38nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 3.90nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 4.51nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 4.89nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 5.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 5.18nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 5.39nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 5.42nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 5.66nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 6.27nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Shijiazhuang Sagacity New Drug Development
US Patent
Shijiazhuang Sagacity New Drug Development
US Patent
Affinity DataIC50: 6.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
